Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on May 6, 2021. The filing serves to report the company's financial results for the first fiscal quarter of 2021. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol FLDM.
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the first fiscal quarter of 2021 were issued on the report date.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The filing explicitly states that the information, including the attached press release, is being "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the May 6, 2021 Press Release), as they are absent from the 8-K body text.
- Confirm the distinction between "furnished" and "filed" information to understand the legal weight of the data in this specific document.
- Check the ticker symbol FLDM on the Nasdaq Global Select Market for current trading status.
- Note that the company name in the metadata request (Standard BioTools Inc.) differs from the registrant in the filing (Fluidigm Corporation); verify if this is a post-filing acquisition or a data entry error.